If you believe you or a loved one is experiencing depression, here's what mental health experts want you to know about ...

No increase in risk for major congenital malformations is observed in infants born to mothers receiving smoking cessation therapies, according to a large cohort study.

But semaglutide isn't without side effects. Some users have reported gastrointestinal issues, and a new study suggests that ...

Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

What the study revealed about GLP-1s and their connection to hair loss The study looked at over 3,200 patients, about 60% of ...

At the recent American Academy of Neurology (AAN) 2025 annual meeting, Axsome Therapeutics (Nasdaq: AXSM) presented promising data for AXS-05 (bupropion + dextromethorphan) in treating agitation ...

Axsome Therapeutics, Inc.’s AXSM share price has dipped by 8.23%, which has investors questioning if this is right time to ...

LifeMD's growth accelerates with expanded insurance, new health products, and a 43% revenue boost. Click here to read our ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...

Although opioid-type medications have come under a lot of scrutiny in recent years, they are still the first-line treatment ...

If you or a loved one is dealing with anxiety, this is everything mental health experts want you to know about the issue and ...